Tumor Lysis Syndrome Market, Global Outlook and Forecast 2022-2028

July 2024 | 60 pages | ID: T62A0E8D4864EN
Market Monitor Global

Abstracts

Tumor lysis syndrome is a group of metabolic abnormalities that can occur as a complication during the treatment of cancer, where large amounts of tumor cells are killed off (lysed) at the same time by the treatment, releasing their contents into the bloodstream.

This report contains market size and forecasts of Tumor Lysis Syndrome in Global, including the following market information:

Global Tumor Lysis Syndrome Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Tumor Lysis Syndrome market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Allopurinol Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Tumor Lysis Syndrome include Harman Finochem, Ironwood Pharmaceuticals, Mylan, AstraZeneca and Takeda Pharmaceutical Company, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Tumor Lysis Syndrome companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Tumor Lysis Syndrome Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Tumor Lysis Syndrome Market Segment Percentages, by Type, 2021 (%)

• Allopurinol
• Febuxostat
• Rasburicase
• Others

Global Tumor Lysis Syndrome Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Tumor Lysis Syndrome Market Segment Percentages, by Application, 2021 (%)

• Hospital Pharmacies
• Retail pharmacies
• Others

Global Tumor Lysis Syndrome Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Tumor Lysis Syndrome Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Tumor Lysis Syndrome revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Tumor Lysis Syndrome revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Harman Finochem
• Ironwood Pharmaceuticals
• Mylan
• AstraZeneca
• Takeda Pharmaceutical Company

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Tumor Lysis Syndrome Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Tumor Lysis Syndrome Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL TUMOR LYSIS SYNDROME OVERALL MARKET SIZE

2.1 Global Tumor Lysis Syndrome Market Size: 2021 VS 2028
2.2 Global Tumor Lysis Syndrome Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Tumor Lysis Syndrome Players in Global Market
3.2 Top Global Tumor Lysis Syndrome Companies Ranked by Revenue
3.3 Global Tumor Lysis Syndrome Revenue by Companies
3.4 Top 3 and Top 5 Tumor Lysis Syndrome Companies in Global Market, by Revenue in 2021
3.5 Global Companies Tumor Lysis Syndrome Product Type
3.6 Tier 1, Tier 2 and Tier 3 Tumor Lysis Syndrome Players in Global Market
  3.6.1 List of Global Tier 1 Tumor Lysis Syndrome Companies
  3.6.2 List of Global Tier 2 and Tier 3 Tumor Lysis Syndrome Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Tumor Lysis Syndrome Market Size Markets, 2021 & 2028
  4.1.2 Allopurinol
  4.1.3 Febuxostat
  4.1.4 Rasburicase
  4.1.5 Others
4.2 By Type - Global Tumor Lysis Syndrome Revenue & Forecasts
  4.2.1 By Type - Global Tumor Lysis Syndrome Revenue, 2017-2022
  4.2.2 By Type - Global Tumor Lysis Syndrome Revenue, 2023-2028
  4.2.3 By Type - Global Tumor Lysis Syndrome Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Tumor Lysis Syndrome Market Size, 2021 & 2028
  5.1.2 Hospital Pharmacies
  5.1.3 Retail pharmacies
  5.1.4 Others
5.2 By Application - Global Tumor Lysis Syndrome Revenue & Forecasts
  5.2.1 By Application - Global Tumor Lysis Syndrome Revenue, 2017-2022
  5.2.2 By Application - Global Tumor Lysis Syndrome Revenue, 2023-2028
  5.2.3 By Application - Global Tumor Lysis Syndrome Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Tumor Lysis Syndrome Market Size, 2021 & 2028
6.2 By Region - Global Tumor Lysis Syndrome Revenue & Forecasts
  6.2.1 By Region - Global Tumor Lysis Syndrome Revenue, 2017-2022
  6.2.2 By Region - Global Tumor Lysis Syndrome Revenue, 2023-2028
  6.2.3 By Region - Global Tumor Lysis Syndrome Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Tumor Lysis Syndrome Revenue, 2017-2028
  6.3.2 US Tumor Lysis Syndrome Market Size, 2017-2028
  6.3.3 Canada Tumor Lysis Syndrome Market Size, 2017-2028
  6.3.4 Mexico Tumor Lysis Syndrome Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Tumor Lysis Syndrome Revenue, 2017-2028
  6.4.2 Germany Tumor Lysis Syndrome Market Size, 2017-2028
  6.4.3 France Tumor Lysis Syndrome Market Size, 2017-2028
  6.4.4 U.K. Tumor Lysis Syndrome Market Size, 2017-2028
  6.4.5 Italy Tumor Lysis Syndrome Market Size, 2017-2028
  6.4.6 Russia Tumor Lysis Syndrome Market Size, 2017-2028
  6.4.7 Nordic Countries Tumor Lysis Syndrome Market Size, 2017-2028
  6.4.8 Benelux Tumor Lysis Syndrome Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Tumor Lysis Syndrome Revenue, 2017-2028
  6.5.2 China Tumor Lysis Syndrome Market Size, 2017-2028
  6.5.3 Japan Tumor Lysis Syndrome Market Size, 2017-2028
  6.5.4 South Korea Tumor Lysis Syndrome Market Size, 2017-2028
  6.5.5 Southeast Asia Tumor Lysis Syndrome Market Size, 2017-2028
  6.5.6 India Tumor Lysis Syndrome Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Tumor Lysis Syndrome Revenue, 2017-2028
  6.6.2 Brazil Tumor Lysis Syndrome Market Size, 2017-2028
  6.6.3 Argentina Tumor Lysis Syndrome Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Tumor Lysis Syndrome Revenue, 2017-2028
  6.7.2 Turkey Tumor Lysis Syndrome Market Size, 2017-2028
  6.7.3 Israel Tumor Lysis Syndrome Market Size, 2017-2028
  6.7.4 Saudi Arabia Tumor Lysis Syndrome Market Size, 2017-2028
  6.7.5 UAE Tumor Lysis Syndrome Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Harman Finochem
  7.1.1 Harman Finochem Corporate Summary
  7.1.2 Harman Finochem Business Overview
  7.1.3 Harman Finochem Tumor Lysis Syndrome Major Product Offerings
  7.1.4 Harman Finochem Tumor Lysis Syndrome Revenue in Global Market (2017-2022)
  7.1.5 Harman Finochem Key News
7.2 Ironwood Pharmaceuticals
  7.2.1 Ironwood Pharmaceuticals Corporate Summary
  7.2.2 Ironwood Pharmaceuticals Business Overview
  7.2.3 Ironwood Pharmaceuticals Tumor Lysis Syndrome Major Product Offerings
  7.2.4 Ironwood Pharmaceuticals Tumor Lysis Syndrome Revenue in Global Market (2017-2022)
  7.2.5 Ironwood Pharmaceuticals Key News
7.3 Mylan
  7.3.1 Mylan Corporate Summary
  7.3.2 Mylan Business Overview
  7.3.3 Mylan Tumor Lysis Syndrome Major Product Offerings
  7.3.4 Mylan Tumor Lysis Syndrome Revenue in Global Market (2017-2022)
  7.3.5 Mylan Key News
7.4 AstraZeneca
  7.4.1 AstraZeneca Corporate Summary
  7.4.2 AstraZeneca Business Overview
  7.4.3 AstraZeneca Tumor Lysis Syndrome Major Product Offerings
  7.4.4 AstraZeneca Tumor Lysis Syndrome Revenue in Global Market (2017-2022)
  7.4.5 AstraZeneca Key News
7.5 Takeda Pharmaceutical Company
  7.5.1 Takeda Pharmaceutical Company Corporate Summary
  7.5.2 Takeda Pharmaceutical Company Business Overview
  7.5.3 Takeda Pharmaceutical Company Tumor Lysis Syndrome Major Product Offerings
  7.5.4 Takeda Pharmaceutical Company Tumor Lysis Syndrome Revenue in Global Market (2017-2022)
  7.5.5 Takeda Pharmaceutical Company Key News

8 CONCLUSION


9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Tumor Lysis Syndrome Market Opportunities & Trends in Global Market
Table 2. Tumor Lysis Syndrome Market Drivers in Global Market
Table 3. Tumor Lysis Syndrome Market Restraints in Global Market
Table 4. Key Players of Tumor Lysis Syndrome in Global Market
Table 5. Top Tumor Lysis Syndrome Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Tumor Lysis Syndrome Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Tumor Lysis Syndrome Revenue Share by Companies, 2017-2022
Table 8. Global Companies Tumor Lysis Syndrome Product Type
Table 9. List of Global Tier 1 Tumor Lysis Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Tumor Lysis Syndrome Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Tumor Lysis Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Tumor Lysis Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Tumor Lysis Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Tumor Lysis Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Tumor Lysis Syndrome Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Tumor Lysis Syndrome Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Tumor Lysis Syndrome Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Tumor Lysis Syndrome Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Tumor Lysis Syndrome Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Tumor Lysis Syndrome Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Tumor Lysis Syndrome Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Tumor Lysis Syndrome Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Tumor Lysis Syndrome Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Tumor Lysis Syndrome Revenue, (US$, Mn), 2023-2028
Table 30. Harman Finochem Corporate Summary
Table 31. Harman Finochem Tumor Lysis Syndrome Product Offerings
Table 32. Harman Finochem Tumor Lysis Syndrome Revenue (US$, Mn), (2017-2022)
Table 33. Ironwood Pharmaceuticals Corporate Summary
Table 34. Ironwood Pharmaceuticals Tumor Lysis Syndrome Product Offerings
Table 35. Ironwood Pharmaceuticals Tumor Lysis Syndrome Revenue (US$, Mn), (2017-2022)
Table 36. Mylan Corporate Summary
Table 37. Mylan Tumor Lysis Syndrome Product Offerings
Table 38. Mylan Tumor Lysis Syndrome Revenue (US$, Mn), (2017-2022)
Table 39. AstraZeneca Corporate Summary
Table 40. AstraZeneca Tumor Lysis Syndrome Product Offerings
Table 41. AstraZeneca Tumor Lysis Syndrome Revenue (US$, Mn), (2017-2022)
Table 42. Takeda Pharmaceutical Company Corporate Summary
Table 43. Takeda Pharmaceutical Company Tumor Lysis Syndrome Product Offerings
Table 44. Takeda Pharmaceutical Company Tumor Lysis Syndrome Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Tumor Lysis Syndrome Segment by Type in 2021
Figure 2. Tumor Lysis Syndrome Segment by Application in 2021
Figure 3. Global Tumor Lysis Syndrome Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Tumor Lysis Syndrome Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Tumor Lysis Syndrome Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Tumor Lysis Syndrome Revenue in 2021
Figure 8. By Type - Global Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 9. By Application - Global Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 10. By Region - Global Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 11. By Country - North America Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 12. US Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 16. Germany Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 17. France Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 24. China Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 28. India Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 30. Brazil Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Tumor Lysis Syndrome Revenue Market Share, 2017-2028
Figure 33. Turkey Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Tumor Lysis Syndrome Revenue, (US$, Mn), 2017-2028
Figure 37. Harman Finochem Tumor Lysis Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Ironwood Pharmaceuticals Tumor Lysis Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Mylan Tumor Lysis Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. AstraZeneca Tumor Lysis Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Takeda Pharmaceutical Company Tumor Lysis Syndrome Revenue Year Over Year Growth (US$, Mn) & (2017-2022)